Product
Recombinant fragment of human surfactant protein D
1 clinical trial
3 indications
Indication
Chronic Lung Disease of PrematurityIndication
Respiratory Distress SyndromeIndication
Bronchopulmonary DysplasiaClinical trial
Phase 1 Safety Trial of Recombinant Surfactant Protein D to Prevent Neonatal Chronic Lung DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-07-01